Endoways

Company Overview

Snapshot

Founded in February 2018 by Tamir Ben David and Noam Shamay, Endoways operates with 1–10 employees. The company was acquired by Ascendum Capital in February 2021, following a funding round in March 2018 that included investments from Israel Innovation Authority.

Business overview

Endoways develops a robotic microcatheter designed for advanced self-propulsion through tortuous blood vessels. This technology aims to simplify complex procedures, reduce overall procedure time, and minimize radiation exposure for both patients and medical staff. Operating within the Health Tech & Life Sciences sector, specifically Medical Devices, Endoways serves the healthcare industry by providing innovative surgical instruments for interventional radiologists.

Strategic signal

Endoways' acquisition by Ascendum Capital in February 2021 signals a successful exit for its early investors and validates the potential of its robotic microcatheter technology. This event highlights the ongoing interest in advanced medical devices that enhance surgical precision and patient safety, positioning Endoways' innovation as a valuable asset within the medical technology landscape.

Company Intelligence Q&A

When was Endoways founded?

Endoways was founded in February 2018.

Who are the founders of Endoways?

Endoways was founded by Tamir Ben David and Noam Shamay.

When was Endoways acquired?

Endoways was acquired by Ascendum Capital in February 2021.

Which investors participated in Endoways' funding round?

In March 2018, Endoways received funding from Israel Innovation Authority and MEDX Xelerator.

What is Endoways' core product?

Endoways has developed a robotic microcatheter with advanced self-propulsion capabilities for navigation through tortuous blood vessels, designed to simplify complex procedures and minimize radiation exposure.